107 related articles for article (PubMed ID: 7149908)
1. Reactivity of human lymphocytes to teratoma preparations as revealed by the macrophage electrophoretic mobility (MEM) technique.
Irmscher J; Grossmann H; Kotzsch M; Wagner H; Müller M
Arch Geschwulstforsch; 1982; 52(5):349-53. PubMed ID: 7149908
[TBL] [Abstract][Full Text] [Related]
2. Reactivity in the MEM-test of cancer patients' lymphocytes incubated with brain-derived preparations and extracts from malignant teratomas.
Müller M; Irmscher J; Grossmann H; Kotzsch M; Wagner H; Kemmer C
Arch Geschwulstforsch; 1981; 51(4):354-63. PubMed ID: 6172087
[TBL] [Abstract][Full Text] [Related]
3. [Cross-reactivity of 3M KCl extracts of fetal tissue from various species in the macrophage electrophoresis mobility (MEM) test. I. Extracts from fetuses of mammals and one species of fowl].
Schlott B; Gryschek G; Reinhöfer J; von Broen B; Pasternak G
Arch Geschwulstforsch; 1983; 53(2):93-8. PubMed ID: 6344836
[TBL] [Abstract][Full Text] [Related]
4. The macrophage electrophoretic mobility assay in patients with renal cell carcinoma.
Malkovský M; Bubeník J; Jakoubková J; Suhajová E; Indrová M; Jandlová T; Símová J
Neoplasma; 1981; 28(2):245-51. PubMed ID: 7254439
[TBL] [Abstract][Full Text] [Related]
5. [Lymphocyte reactivity against fetal antigens during the growth and regression of experimental tumors].
Schlott B; Gryschek G; Albrecht S; Pasternak G
Biomed Biochim Acta; 1985; 44(5):805-11. PubMed ID: 4062925
[TBL] [Abstract][Full Text] [Related]
6. [Reaction of inhibition of macrophage electrophoretic mobility in differential diagnosis of carcinomas].
Miuller M; Irmsher Iu; Fisher R; Grosmann G
Vopr Onkol; 1976; 22(12):43-50. PubMed ID: 1020256
[TBL] [Abstract][Full Text] [Related]
7. [Pre- and postoperative reactivity of breast cancer patients to tumor associated antigens and HEP in the macrophage electrophoresis mobility (MEM) test].
Ladusch M; Schäffner H; Ullmann L; Littmann M; Reimann S; Gindl P; Ambrosius H
Arch Geschwulstforsch; 1982; 52(6):469-78. PubMed ID: 6186223
[TBL] [Abstract][Full Text] [Related]
8. Studies with the macrophage migration inhibition (MMI) test in patients with malignant disease.
Light PA; Preece AW; Waldron HA
Clin Exp Immunol; 1975 Nov; 22(2):279-84. PubMed ID: 55328
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte sensitization detected by the macrophage electrophoretic mobility assay in patients with renal cell carcinoma: Theophylline increases the sensitivity of the assay.
Malkovský M; Bubeník J; Malkovská V; Indrová M; Suhajová E; Jakoubková J; Jíra M
Arch Geschwulstforsch; 1981; 51(4):364-70. PubMed ID: 7032451
[TBL] [Abstract][Full Text] [Related]
10. Sensitization of normal mouse lymphocytes immunized in vitro as detected by macrophage electrophoretic mobility (MEM) test.
Nĕmecková S; Bubeník J; Indrová M
Folia Biol (Praha); 1982; 28(4):280-2. PubMed ID: 7141039
[TBL] [Abstract][Full Text] [Related]
11. [Discrimination of nonspecific effects in the macrophage-electrophoretic-mobility test using dimethyl sulfoxide].
Wagner H; Irmscher J; Kotzsch M; Grossmann H; Müller M
Biomed Biochim Acta; 1983; 42(1):129-37. PubMed ID: 6192810
[TBL] [Abstract][Full Text] [Related]
12. The macrophage electrophoretic mobility (MEM) test--an investigation of its value as a routine laboratory test in the detection of malignant disease.
Pritchard JA; Sutherland WH; Teasdale C; Whitehead RH; Deeley TJ; Hughes LE
Ann Clin Res; 1978 Apr; 10(2):71-4. PubMed ID: 354473
[TBL] [Abstract][Full Text] [Related]
13. KCl carcinoma extracts as tumor antigens in the electrophoretic mobility test: clinical evaluation.
Muhrer KH; Link KH
Cancer Detect Prev; 1983; 6(1-2):101-6. PubMed ID: 6883371
[TBL] [Abstract][Full Text] [Related]
14. Reactivity in neoplasia, preneoplasia, and pregnancy of lymphocytes against fetal extracts: cross-reactions between man and mouse.
Pasternak G; Schlott B; Reinhöfer J; Gryschek G; von Broen B; Albrecht S
J Natl Cancer Inst; 1982 Nov; 69(5):997-1004. PubMed ID: 6957663
[TBL] [Abstract][Full Text] [Related]
15. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.
Field EJ; Caspary EA; Smith KS
Br J Cancer Suppl; 1973 Aug; 1():208-14. PubMed ID: 4140728
[TBL] [Abstract][Full Text] [Related]
16. Immunological tumour profile: organ-specific carcinoma diagnosis in patients employing the macrophage electrophoretic mobility test.
Müller M; Irmscher J; Fischer R; Heidl G; Grossmann H
Cancer Lett; 1977 Jan; 2(3):139-45. PubMed ID: 65215
[TBL] [Abstract][Full Text] [Related]
17. The leukocyte adherence inhibition test in tumor patients using 3M KCl extracts of fetal tissues as antigens.
Albrecht S; Schlott B; Pasternak G; Reinhöfer J; Lunow G
Arch Geschwulstforsch; 1982; 52(5):341-8. PubMed ID: 7149907
[TBL] [Abstract][Full Text] [Related]
18. [Determination of the MSF (macrophage slowing factor) release by phytohemagglutinin using the macrophage electrophoretic mobility test (MEM test). I. Dependency of release on incubation time, phytohemagglutinin and cell concentration].
Metzner G; Jäger L
Acta Biol Med Ger; 1980; 39(2-3):223-7. PubMed ID: 6999821
[TBL] [Abstract][Full Text] [Related]
19. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary.
Suzuki M; Tamura N; Kobayashi H; Ohwada M; Terao T; Sato I
Gynecol Oncol; 2000 Jun; 77(3):405-9. PubMed ID: 10831350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
